Download presentation
Presentation is loading. Please wait.
Published byReynold Anthony Modified over 5 years ago
1
Effect of omalizumab on change from baseline (B) in a) total asthma symptom score, b) total rhinitis symptom score, and c) combined asthma and rhinitis symptom score (least square mean±sem). •: omalizumab (n = 135); ▪: current asthma therapy alone (n = 70).... Effect of omalizumab on change from baseline (B) in a) total asthma symptom score, b) total rhinitis symptom score, and c) combined asthma and rhinitis symptom score (least square mean±sem). •: omalizumab (n = 135); ▪: current asthma therapy alone (n = 70). #: n = 54; ¶: n = 51; +: n = 46; §: n = 126; ƒ: n = 124; ##: n = 120; ¶¶: n = 117. ***: p< (J. Bousquet, Service des Maladies Respiratories, Montpellier, France; personal communication). J. Bousquet et al. Eur Respir Rev 2008;17:1-9 ©2008 by European Respiratory Society
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.